CPT® Code 0465T

Deleted

The CPT® Code 0465T refers to the procedure of a suprachoroidal injection of a pharmacologic agent, which is a targeted therapeutic intervention used primarily for treating various diseases affecting the posterior segment of the eye. This includes conditions such as age-related macular degeneration, retinal vein occlusion, and diabetic macular edema. The suprachoroidal space, where the injection occurs, is a narrow anatomical area located between the choroid and the sclera, extending from the limbus (the border between the cornea and the sclera) to the optic nerve. This space is characterized by a defined inner layer of the choroid known as Bruch’s membrane, along with an outer layer that transitions close to the sclera, consisting of several fibrous lamellae that vary in thickness. During the procedure, a specialized handheld microinjector, which includes a syringe and a very fine needle, is utilized to deliver the pharmacologic agent. The needle is carefully inserted through the sclera, allowing the fluid to be injected into the posterior segment of the eye, where it disperses around the globe and throughout the choroid and retina. It is important to note that while Code 0465T captures the injection procedure itself, the pharmacologic agent used in the injection must be reported separately, as it is not included in this code.